Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 80 citing articles:

Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study
Chris Callaghan, Rebecca Curtis, Lisa Mumford, et al.
Transplantation (2023) Vol. 107, Iss. 5, pp. 1124-1135
Open Access | Times Cited: 11
The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis
Xiu Hong Yang, Wen Jing Bao, Hua Zhang, et al.
Journal of General Internal Medicine (2023)
Open Access | Times Cited: 11
Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France
Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, et al.
Vaccine (2023) Vol. 41, Iss. 17, pp. 2754-2760
Open Access | Times Cited: 10
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector P. Rodríguez, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1194-1203
Open Access | Times Cited: 10
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study
Jennifer H. Ku, Lina S. Sy, Lei Qian, et al.
Vaccine (2023) Vol. 41, Iss. 29, pp. 4212-4219
Open Access | Times Cited: 9
Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile
Alejandro Jara, Cristóbal Cuadrado, Eduardo A. Undurraga, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Effectiveness of a Fourth Dose of COVID-19 mRNA Vaccine Against Omicron Variant Among Elderly People in Singapore
Celine Y. Tan, Calvin J. Chiew, Vernon J. Lee, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 11, pp. 1622-1623
Open Access | Times Cited: 15
Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Hung Fu Tseng, Bradley K. Ackerson, Katia Bruxvoort, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
Tal Patalon, Yaki Saciuk, Galit Perez, et al.
The Journal of Pediatrics (2023) Vol. 257, pp. 113371-113371
Open Access | Times Cited: 8
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study
Soledad González, Santiago Olszevicki, Alejandra Gaiano, et al.
The Lancet Regional Health - Americas (2023) Vol. 27, pp. 100607-100607
Open Access | Times Cited: 8
Changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS): a two-year prospective cohort study in Israel
Shachar Snir, Yupeng Chen, Matan Yechezkel, et al.
The Lancet Regional Health - Europe (2024) Vol. 42, pp. 100934-100934
Open Access | Times Cited: 2
Rapid waning of protection induced by prior BA.1/BA.2 infection against BA.5 infection
João Malato, Ruy M. Ribeiro, Eugénia Fernandes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis
Kaixin Guo, Peng Ni, Shuailei Chang, et al.
American Journal of Infection Control (2023) Vol. 51, Iss. 9, pp. 1049-1055
Closed Access | Times Cited: 7
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study
Massimo Fabiani, Alberto Mateo‐Urdiales, Chiara Sacco, et al.
Vaccine (2022) Vol. 41, Iss. 1, pp. 76-84
Open Access | Times Cited: 11
Effectiveness and Duration of Protection of a Fourth Dose of Coronavirus Disease 2019 Messenger RNA Vaccine Among Long-term Care Residents in Ontario, Canada
Ramandip Grewal, Lena Nguyen, Sarah A. Buchan, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 8, pp. 977-980
Open Access | Times Cited: 11
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
Nathaniel M. Lewis, Nancy L. Murray, Katherine Adams, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study
Jessica A. Breznik, Ahmad Rahim, Hina Bhakta, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 5
Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study
María Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Diego Rivera-Salinas, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1139-1139
Open Access | Times Cited: 9
Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI)
Oliver Stirrup, Madhumita Shrotri, Natalie Adams, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review
Sabina Rodriguez Velásquez, Loza Biru, Sandrine Marie Hakiza, et al.
Schweizerische medizinische Wochenschrift (2024) Vol. 154, Iss. 5, pp. 3732-3732
Open Access | Times Cited: 1
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case-Control Study
Hyerin Gim, Haesook Seo, Byung Chul Chun
Journal of Korean Medical Science (2024) Vol. 39, Iss. 21
Open Access | Times Cited: 1
Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence
Pedro Pablo España, Idoia Castillo-Sintes, María José Legarreta, et al.
Age and Ageing (2024) Vol. 53, Iss. 11
Closed Access | Times Cited: 1
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Ramandip Grewal, Lena Nguyen, Sarah A. Buchan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months
Dominik Dietler, Fredrik Kahn, Malin Inghammar, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 12, pp. 1573-1580
Open Access | Times Cited: 4
Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older
Esther Saiag, Yifat Alcalay, Or Marudi, et al.
Vaccine (2022) Vol. 41, Iss. 4, pp. 914-921
Open Access | Times Cited: 6

Scroll to top